Condition

Poor Ovarian Response clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Poor Ovarian Response clinical trials that are recruiting, at sites in 2 countries (most in Spain (2), China (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Poor Ovarian Response clinical trials

StudyPhaseWhereStatusRegistered
Ovulation Trigger Strategies for Women with Low Ovarian Reserve Phase 3 Valencia Recruiting Sep 11, 2026
Proteomic profiling of plasma before and after stem cell mobilization in poor ovarian responders — Alicante, Alicante Recruiting Jan 29, 2026
Using Platelet-rich Plasma to Improve Female Fertility — Yiwu, Zhejiang Recruiting Oct 16, 2024

All recruiting trials (3)

Related topics

Intrauterine AdhesionPremature Ovarian Insufficiency

Quick answers

How many Poor Ovarian Response clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Spain (2 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.